Initial Data Suggest NuvoAir Virtual First Clinical Service for COPD Increases Patient Engagement and Reduces Hospitalizations

Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death and disability in the United States, with an estimated 12 million people who remain undiagnosed. The impact of COPD in terms of quality of life and cost of care is substantial, yet studies have found inadequacies in current health systems to meet the complex needs of COPD patients.

In 2021, NuvoAir initiated a small pilot with the roll-out of virtual COPD clinical services in the United States. Data show successful engagement and reported health outcomes with 80% reporting fewer COPD related hospitalizations since joining the NuvoAir Clinical Service.

In this white paper, you will more learn more about:

  • The NuvoAir Clinical Service and how its innovative approach is supporting people with COPD
  • Data collected from an initial pilot with two clinical sites
  • Opportunities to engage individuals with COPD to improve quality of life and reduce hospitalizations and related healthcare costs